自体前囊膜作为巩膜内间隔物在深巩膜切除术中的应用:一项随机临床试验
本研究为前瞻性随机平行组临床试验,纳入60例药物不可控青光眼合并白内障成人患者,比较超声乳化联合深巩膜切除术(PE-DS)加或不加自体前囊膜间隔物的效果。结果显示加用间隔物组在6个月和12个月时眼压显著更低,在严格成功标准下累积成功率更高,用药差异呈统计趋势。
要点
- PE-DS加自体前囊膜间隔物在6和12个月眼压显著低于单纯PE-DS。
- 严格IOP≤12 mmHg成功标准下,间隔物组累积成功率47.5% vs 15.5%(P=0.025)。
- 间隔物组用药更少,但组间差异仅呈统计趋势(P=0.063和0.094)。
核心结论
- PE-DS联合自体前囊膜间隔物与6和12个月时更低的眼压相关,并在严格眼压阈值下具有更高的累积成功率。
研究设计与样本
- 前瞻性、随机、平行组临床试验,纳入60例60眼药物不可控青光眼合并视力显著白内障的成人患者,随访至少12个月。
主要发现
- 两组基线眼压相似(25.14±9.62 vs 23.77±5.18 mmHg),所有随访点均显著下降。
- 间隔物组第6个月眼压显著更低(11.90±1.82 vs 13.13±2.20 mmHg;P=0.022)。
- 间隔物组第12个月眼压显著更低(12±2.20 vs 13.29±2.68 mmHg;P=0.042)。
- 间隔物组第6个月用药更少(0.14±0.45 vs 0.48±0.85;P=0.063)。
- 间隔物组第12个月用药更少(0.29±0.66 vs 0.68±1.04;P=0.094)。
关键数值与推荐
- 严格成功定义C(IOP≤12 mmHg)下,间隔物组累积成功率47.5%,对照组15.5%(log-rank检验P=0.025)。
临床怎么用
- 在PE-DS术中加用自体前囊膜间隔物可能有助于进一步降低眼压并提高严格标准下的手术成功率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare deep sclerectomy (DS) combined with phacoemulsification (PE), with versus without an autologous anterior lens capsule spacer. DESIGN: Prospective, randomized, parallel-group clinical trial. METHODS: Sixty eyes of 60 adults with medically uncontrolled glaucoma and visually significant cataracts underwent PE-DS with an autologous anterior capsule spacer (Spacer group) or PE-DS alone (Control group). Follow-up was at least 12 months. The primary outcome was change in intraocular pressure (IOP) from baseline through 12 months. Secondary outcomes included glaucoma medication use, surgical success according to prespecified IOP-based criteria, and adverse events. RESULTS: Baseline IOP was similar (25.14 ± 9.62 vs 23.77 ± 5.18 mmHg) and both study groups had significant IOP reduction at all visits. IOP was significantly lower in the spacer group at month 6 (11.90 ± 1.82 vs 13.13 ± 2.20 mmHg; P = 0.022) and month 12 (12 ± 2.20 vs 13.29 ± 2.68 mmHg; P = 0.042). Medication use was lower in eyes with an autologous spacer at months 6 (0.14 ± 0.45 vs 0.48 ± 0.85; P= 0.063) and 12 (0.29 ± 0.66 vs 0.68 ± 1.04; P =0.094). Under stringent success definitions, survival favored the spacer (e.g., Definition C: IOP≤12 mmHg: 47.5% vs 15.5%; log-rank test P = 0.025). CONCLUSIONS AND RELEVANCE: Adding an autologous anterior capsule spacer during PE-DS was associated with lower IOP at 6 and 12 months and higher cumulative success under stringent IOP thresholds. Medication use was lower in the spacer group, although the between-group differences showed a trend toward statistical significance.
引用
- Einollahi N, Doozandeh A, Rezaei J, et al. Autologous Anterior Lens Capsule as an Intrascleral Spacer in Deep Sclerectomy: A Randomized Clinical Trial. Am J Ophthalmol. 2026. PMID: 42946033. doi:10.1016/j.ajo.2026.10.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。